Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Four peptides decrease the number of human pancreatic adenocarcinoma cells.

B A Vesely1, Q McAfee, W R Gower

  • 1Department of Medicine, University of South Florida Cardiac Hormone Center, Tampa, FL 33612, USA.

European Journal of Clinical Investigation
|November 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line.

In vitro cellular & developmental biology. Animal·2015
Same author

Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.

European journal of clinical investigation·2010
Same author

Cardiac hormones activate ERK 1/2 kinases in human fibroblasts.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2008
Same author

Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.

European journal of clinical investigation·2008
Same author

Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells.

Oncogene·2006
Same author

Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.

European journal of clinical investigation·2006
Same journal

Pacemaker Status and 5-Year Mortality After TAVI: A Sex-Specific Analysis.

European journal of clinical investigation·2026
Same journal

Causal Effects of Time-Varying Treatments: The G-Formula.

European journal of clinical investigation·2026
Same journal

Improving Scientific Research: Renegotiated Principles of Science, Proposals, Failures, and Successes.

European journal of clinical investigation·2026
Same journal

Beta-Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta-Analysis With Trial Sequential Analysis.

European journal of clinical investigation·2026
Same journal

Prognostic Role of Serum Albumin Levels in Elderly Patients With Non-Valvular Atrial Fibrillation.

European journal of clinical investigation·2026
Same journal

Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.

European journal of clinical investigation·2026
See all related articles

Four peptide hormones significantly reduce pancreatic cancer cell numbers and inhibit proliferation by blocking DNA synthesis. These findings offer potential new therapeutic strategies for pancreatic adenocarcinoma.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Four peptide hormones—long-acting natriuretic peptide, vessel dilator, kaliuretic peptide, and atrial natriuretic peptide—are synthesized from the same gene.
  • These hormones are known for their roles in sodium and water excretion and blood pressure regulation.

Purpose of the Study:

  • To evaluate the effects of these four peptide hormones on human pancreatic adenocarcinoma cells in culture.
  • To determine if these hormones can decrease cancer cell number and/or proliferation.

Main Methods:

  • Human pancreatic adenocarcinoma cells were cultured and treated with 1-micromolar concentrations of the four peptide hormones.
  • Cell counts, proliferation, and DNA synthesis were assessed at 24, 48, 72, and 96 hours.

Related Experiment Videos

Main Results:

  • All four peptide hormones significantly decreased pancreatic cancer cell numbers within 24 hours, with vessel dilator showing the greatest effect (65% decrease).
  • The antiproliferative effect was sustained for at least 96 hours, with no observed cancer cell proliferation.
  • The mechanism involved significant inhibition of DNA synthesis (≥83%), not apoptosis, mediated partly by cyclic GMP and prostaglandin E2.

Conclusions:

  • The four peptide hormones effectively reduce pancreatic adenocarcinoma cell count and inhibit proliferation.
  • Inhibition of DNA synthesis, partly mediated by cyclic GMP, is the primary mechanism of action.